株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ブラジルのバイオマテリアル市場(2010年〜2015年)

Brazil Biomaterial Market (2010 - 2015)

発行 MarketsandMarkets 商品コード 191856
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
ブラジルのバイオマテリアル市場(2010年〜2015年) Brazil Biomaterial Market (2010 - 2015)
出版日: 2011年05月11日 ページ情報: 英文 179 Pages
概要

ブラジルのバイオマテリル(生体材料)市場は、2008年の5億5,020万米ドルから2015年には17億米ドルに拡大すると予測されています。2010年には、整形外科用バイオマテリアル市場は全体市場の37.5%を占める2億3,650万米ドルの収益を記録しました。これは応用分野の広がりや高度技術の導入によるものです。第2位の心血管用バイオマテリアル市場は2010年に全体市場の36%を占めました。

当レポートでは、ブラジルのバイオマテリアル市場を製品別、材料別、用途別に分析し、それぞれの概況、発展要因、動向、機会、競合環境を探り、また参入企業のプロファイルも交え、概略以下の構成でお届けします。

エグゼクティブサマリー

第1章 イントロダクション

第2章 サマリー

第3章 市場概要

  • イントロダクション
  • ブラジルのバイオマテリアル市場の定義
  • 市場規模
  • ブラジルの法規制プロセス
  • ブラジルのバイオマテリアル市場の牽引因子

第4章 製品別市場

  • イントロダクション
  • 整形外科用バイオマテリアル
  • 心血管用バイオマテリアル
  • 創傷用バイオマテリアル
  • 形成外科バイオマテリアル
  • 泌尿器用バイオマテリアル
  • 消化管用バイオマテリアル

第5章 材料市場

  • イントロダクション
  • 金属
  • セラミック
  • ポリマー

第6章 用途別市場

  • イントロダクション
  • 手術用品・備品
  • 手術機器、医療機器
  • ドラッグデリバリー
  • 一般外科
  • 電気医療機器
  • 歯科製品
  • その他

第7章 企業プロファイル

付録

目次
Product Code: BT 1607

The Brazil market for biomaterials is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.

Aging population (population above 60 years is expected to reach 24 million by 2012), higher life expectancy, and increase in the incidences of ‘lifestyle and chronic diseases' such as cardiovascular diseases has influenced the growth of biomaterial products. According to the World Health Organization, 32% of the total mortality in Brazil is due to cardiovascular diseases. Such a high incidence of diseases will increase the demand for cardiovascular biomaterial products such as cardiac stents.

The biomaterial products market in Brazil is expected to grow from $690 million in 2010 to $1.7 billion in 2015 at an estimated CAGR of 19.5%. The wound care biomaterial segment is expected to grow at a CAGR of 24.3% from 2010 to 2015. Of all the application areas of biomaterial in Brazil, surgical appliances and supplies account for the largest share; i.e. 39% of the total applications of biomaterial. With the technological advancements in orthopedic and prosthetic applications, there is an increase in demand for biomaterials in surgical appliances and supplies.

Markets covered

This research report categorizes the biomaterials market into the following:

  • Biomaterial market, by products: Orthopedic, cardiovascular, wound care, gastrointestinal, urological, plastic surgery and others.
  • Biomaterial market, by materials: Metals, polymers, ceramics, and composites.
  • Biomaterial market, by application: General surgery, surgical appliances and supplies, surgical and medical instruments, dental products, electro medical equipment, and other applications.
  • The report provides market estimates and forecasts for the Brazil biomaterial market. Plus, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the biomaterials market. The report also draws a competitive landscape, analyzing core competencies of major players and strategies adopted to expand their market presence.

Table of Contents

EXECUTIVE SUMMARY

  • MARKET OVERVIEW

1. INTRODUCTION

  • 1.1 KEY TAKE-AWAYS
  • 1.2 REPORT DESCRIPTION
  • 1.3 MARKETS COVERED
  • 1.4 STAKEHOLDERS
  • 1.5 RESEARCH METHODOLOGY

2. SUMMARY

3. MARKET OVERVIEW

  • 3.1 INTRODUCTION
  • 3.2 DEFINING THE BRAZIL BIOMATERIALS MARKET
  • 3.3 MARKET SIZE
  • 3.4 BRAZIL REGULATORY PROCESS
  • 3.5 DRIVING FACTOR ANALYSIS OF BRAZIL BIOMATERIALS MARKET
    • 3.5.1 DEMAND SIDE DRIVERS
    • 3.5.2 SUPPLY SIDE DRIVERS
    • 3.5.3 THREATS
    • 3.5.4 OPPORTUNITIES
    • 3.5.5 KEY COMPETITIVE POINTS

4. BIOMATERIALS MARKET - BY PRODUCTS

  • 4.1 INTRODUCTION
  • 4.2 ORTHOPEDIC BIOMATERIALS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Product penetration
      • 4.2.1.2 Easy surgical procedures
    • 4.2.2 RECONSTRUCTIVE BIOMATERIALS
      • 4.2.2.1 Artificial knee biomaterials
        • 4.2.2.1.1 Constraint implants
        • 4.2.2.1.2 Non-constraint implants
        • 4.2.2.1.3 Semi-constraint implants
      • 4.2.2.2 Artificial hip biomaterials
        • 4.2.2.2.1 Cemented prostheses biomaterials
        • 4.2.2.2.2 Uncemented prostheses biomaterials
    • 4.2.3 ORTHOBIOLOGICS BIOMATERIALS
      • 4.2.3.1 Machined bone allografts
      • 4.2.3.2 DBM
      • 4.2.3.3 BMP
      • 4.2.3.4 Synthetic bone substitutes
      • 4.2.3.5 Non-proprietary allografts
      • 4.2.3.6 Platelet concentrates
    • 4.2.4 BONE CEMENT
    • 4.2.5 TRAUMA ORTHOPEDIC BIOMATERIALS
    • 4.2.6 SPINAL ORTHOPEDIC BIOMATERIALS
      • 4.2.6.1 Cervical
      • 4.2.6.2 Lumbar
    • 4.2.7 SPORTS MEDICINE
    • 4.2.8 DENTAL ORTHOPEDIC BIOMATERIALS
      • 4.2.8.1 Dental bone graft
        • 4.2.8.1.1 Dental allograft
        • 4.2.8.1.2 Dental synthetic
        • 4.2.8.1.3 Dental xenograft
      • 4.2.8.2 Dental membranes
      • 4.2.8.3 Tissue regeneration
  • 4.3 CARDIOVASCULAR BIOMATERIALS
    • 4.3.1 CARDIAC STENTS
    • 4.3.2 PERIPHERAL VASCULAR GRAFTS
    • 4.3.3 VASCULAR ACCESS DEVICES
    • 4.3.4 CARDIAC PACEMAKERS
    • 4.3.5 ARTIFICIAL HEART VALVES
    • 4.3.6 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
  • 4.4 WOUND CARE BIOMATERIALS
    • 4.4.1 SURGICAL HEMOSTATS
      • 4.4.1.1 Thrombin-based hemostats
      • 4.4.1.2 Oxidized regenerated cellulose-based hemostats
      • 4.4.1.3 Collagen-based hemostats
      • 4.4.1.4 Autologous-based biomaterials
      • 4.4.1.5 Polysaccharide-based biomaterials
      • 4.4.1.6 Gelatin-based hemostats
      • 4.4.1.7 Combination hemostats
    • 4.4.2 SKIN SUBSTITUTES
    • 4.4.3 INTERNAL TISSUE SEALANT
      • 4.4.3.1 Fibrin-based sealants
      • 4.4.3.2 Synthetic based sealants
    • 4.4.4 ADHESION BARRIERS
      • 4.4.4.1 Gels
      • 4.4.4.2 Films
  • 4.5 PLASTIC SURGERY BIOMATERIALS
    • 4.5.1 FACIAL IMPLANTS
    • 4.5.2 INJECTABLE FILLERS
    • 4.5.3 BREAST IMPLANTS
      • 4.5.3.1 Silicone gel implants
      • 4.5.3.2 Saline-filled implants
  • 4.6 UROLOGICAL BIOMATERIALS
    • 4.6.1 STENTS
    • 4.6.2 CATHETERS
      • 4.6.2.1 Dialysis catheters
      • 4.6.2.2 Urinary catheters
  • 4.7 GASTROINTESTINAL BIOMATERIALS

5. BIOMATERIALS MARKET - BY MATERIALS

  • 5.1 INTRODUCTION
  • 5.2 METALS
    • 5.2.1 PURE FORM METALS
      • 5.2.1.1 Titanium
      • 5.2.1.2 Platinum
      • 5.2.1.3 Silver
      • 5.2.1.4 Gold
    • 5.2.2 ALLOYS
      • 5.2.2.1 High carbon cobalt-chromium alloys
  • 5.3 CERAMICS
    • 5.3.1 BIOINERT
      • 5.3.1.1 Alumina
      • 5.3.1.2 Zirconia
      • 5.3.1.3 Others
    • 5.3.2 BIOACTIVE
      • 5.3.2.1 Bioglass
      • 5.3.2.2 Other bioactive ceramics market
    • 5.3.3 BIODEGRADABLE
      • 5.3.3.1 Hydroxyapetite
      • 5.3.3.2 Other biodegradable biomaterial market
  • 5.4 POLYMERS
    • 5.4.1 NATURAL POLYMERS
      • 5.4.1.1 Collagen based
      • 5.4.1.2 Other protein based
      • 5.4.1.3 Chitosan
      • 5.4.1.4 Alginate
    • 5.4.2 SYNTHETIC POLYMERS
      • 5.4.2.1 Hyaluronic acid
      • 5.4.2.2 PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)
      • 5.4.2.3 PTFE (polytetrafluoroethylene)
      • 5.4.2.4 Other synthetic polymers

6. BIOMATERIALS MARKET - BY APPLICATIONS

  • 6.1 INTRODUCTION
  • 6.2 SURGICAL APPLIANCES & SUPPLIES
  • 6.3 SURGICAL & MEDICAL INSTRUMENTS
  • 6.4 DRUG DELIVERY
  • 6.5 GENERAL SURGERY
  • 6.6 ELECTROMEDICAL EQUIPMENT
  • 6.7 DENTAL PRODUCTS
  • 6.8 OTHERS

7. COMPANY PROFILES

  • 7.1 ALLERGAN INC.
    • 7.1.1 OVERVIEW
    • 7.1.2 FINANCIALS
    • 7.1.3 PRODUCTS & SERVICES
    • 7.1.4 STRATEGY
    • 7.1.5 DEVELOPMENTS
  • 7.2 ALPHATEC SPINE INC.
    • 7.2.1 OVERVIEW
    • 7.2.2 FINANCIALS
    • 7.2.3 PRODUCTS & SERVICES
    • 7.2.4 STRATEGY
    • 7.2.5 DEVELOPMENTS
  • 7.3 ARTIMPLANT AB
    • 7.3.1 OVERVIEW
    • 7.3.2 PRODUCTS & SERVICES
    • 7.3.3 STRATEGY
    • 7.3.4 DEVELOPMENTS
  • 7.4 BAXTER INTERNATIONAL INC.
    • 7.4.1 OVERVIEW
    • 7.4.2 FINANCIALS
    • 7.4.3 PRODUCTS & SERVICES
    • 7.4.4 STRATEGY
    • 7.4.5 DEVELOPMENTS
  • 7.5 BIOMET INC.
    • 7.5.1 OVERVIEW
    • 7.5.2 FINANCIALS
    • 7.5.3 PRODUCTS & SERVICES
    • 7.5.4 STRATEGY
    • 7.5.5 DEVELOPMENTS
  • 7.6 BOSTON SCIENTIFIC CORPORATION
    • 7.6.1 OVERVIEW
    • 7.6.2 FINANCIALS
    • 7.6.3 PRODUCTS & SERVICES
    • 7.6.4 STRATEGY
    • 7.6.5 DEVELOPMENTS
  • 7.7 INTEGRA LIFE SCIENCES HOLDINGS CORPORATION
  • 7.7.1 OVERVIEW
    • 7.7.2 FINANCIALS
    • 7.7.3 PRODUCTS & SERVICES
    • 7.7.4 STRATEGY
    • 7.7.5 DEVELOPMENTS
  • 7.8 STRYKER CORPORATION
    • 7.8.1 OVERVIEW
    • 7.8.2 FINANCIALS
    • 7.8.3 PRODUCTS & SERVICES
    • 7.8.4 STRATEGY
    • 7.8.5 DEVELOPMENTS
  • 7.9 SYNTHES INC.
    • 7.9.1 OVERVIEW
    • 7.9.2 FINANCIALS
    • 7.9.3 PRODUCTS & SERVICES
    • 7.9.4 STRATEGY
    • 7.9.5 DEVELOPMENTS
  • 7.10 WRIGHT MEDICAL GROUP, INC.
    • 7.10.1 OVERVIEW
    • 7.10.2 FINANCIALS
    • 7.10.3 PRODUCTS & SERVICES
    • 7.10.4 STRATEGY
    • 7.10.5 DEVELOPMENTS

LIST OF TABLES

  • 1. BRAZIL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 2. BRAZIL: ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 3. BRAZIL: ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 4. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 5. BRAZIL: ORTHOPEDIC RECONSTRUCTIVE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 6. BRAZIL: ORTHOPEDIC RECONSTRUCTIVE MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 7. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 8. BRAZIL: ARTIFICIAL KNEE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 9. BRAZIL: ARTIFICIAL HIP BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 10. BRAZIL: ORTHOBIOLOGICS BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 11. BRAZIL: ORTHOBIOLOGICS BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 12. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 13. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 14. BRAZIL: TRAUMA ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 15. BRAZIL: TRAUMA ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 16. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 17. BRAZIL: SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 18. BRAZIL: SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 19. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 20. BRAZIL: CERVICAL SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 21. BRAZIL: LUMBAR SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 22. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 23. BRAZIL: DENTAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 24. BRAZIL: DENTAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 25. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 26. BRAZIL: DENTAL BONEGRAFT ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 27. BRAZIL: CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 28. BRAZIL: CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 29. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 30. BRAZIL: CARDIAC STENTS CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 31. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 32. BRAZIL: VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 33. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 34. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 35. BRAZIL: ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 36. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 37. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 38. BRAZIL: WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 39. BRAZIL: WOUND CARE BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 40. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 41. BRAZIL: SURGICAL HEMOSTATS WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 42. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 43. BRAZIL: INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 44. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 45. BRAZIL: ADHESION BARRIERS WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 46. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 47. BRAZIL: PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 48. BRAZIL: PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 49. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 50. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 51. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 52. BRAZIL: BREAST IMPLANTS PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 53. BRAZIL: BREAST IMPLANTS PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 54. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 55. BRAZIL: UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 56. BRAZIL: UROLOGICAL BIOMATERIALS MARKET REVENUE, BY DEVICES 2008-2015 ($THOUSAND)
  • 57. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 58. BRAZIL: CATHETER UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 59. BRAZIL: DIALYSIS CATHETER UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 60. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 61. BRAZIL: URINARY CATHETER UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008-2015 ($THOUSAND)
  • 62. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 63. BRAZIL: BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 64. BRAZIL: METALS BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 65. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 66. BRAZIL: PURE FORM METALS BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 67. BRAZIL: ALLOY BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 68. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 69. BRAZIL CERAMICS BIOMATERIALS MARKET, BY TYPES 2008-2015 ($THOUSAND)
  • 70. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 71. TECHNOLOGICAL ADVANCEMENTS
  • 72. BRAZIL: BIOINERT CERAMICS BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 73. BRAZIL: BIOACTIVE CERAMICS BIOMATERIALS MARKET REVENUE BY TYPES 2008-2015 ($THOUSAND)
  • 74. BRAZIL: BIODEGRADABLE CERAMICS BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 75. BRAZIL: POLYMER BIOMATERIALS MARKET REVENUE, BY POLYMERS 2008-2015 ($THOUSAND)
  • 76. MAJOR PLAYERS & PRODUCT DEVELOPMENT
  • 77. BRAZIL: NATURAL POLYMER BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 78. BRAZIL: SYNTHETIC POLYMER BIOMATERIALS MARKET REVENUE, BY TYPES 2008-2015 ($THOUSAND)
  • 79. BRAZIL APPLICATIONS MARKET REVENUE, 2008-2015 ($THOUSAND)
  • 80. ALLERGAN REVENUES AND R&D EXPENSES ($MILLION)
  • 81. ALLERGAN REVENUES, BY SEGMENT ($MILLION)
  • 82. ALLERGAN MEDIACL DEVICES REVENUES, BY SEGMENT ($MILLION)
  • 83. ALLERGAN REVENUES, BY GEOGRAPHY ($MILLION)
  • 84. ALPHATEC SPINE REVENUES AND R&D EXPENSES ($MILLION)
  • 85. APLHATEC SPINE REVENUES, BY GEOGRAPHY ($MILLION)
  • 86. BAXTER SALES, BY SEGMENT ($MILLION)
  • 87. BAXTER SALES, BY GEOGRAPHY ($MILLION)
  • 88. BIOMET REVENUES AND R&D EXPENSES ($MILLION)
  • 89. BIOMET REVENUES, BY SEGMENT ($MILLION)
  • 90. BOSTON SCIENTIFIC REVENUES AND R&D EXPENSES ($MILLION)
  • 91. BOSTON SCIENTIFIC REVENUES, BY GEOGRAPHY ($MILLION)
  • 92. INTEGRA REVENUES AND R&D EXPENSES ($MILLION)
  • 93. INTEGRA REVENUES, BY GEOGRAPHY ($MILLION)
  • 94. INTEGRA REVENUES, BY SEGMENTS ($MILLION)
  • 95. STRYKER REVENUES AND R&D EXPENSES ($MILLION)
  • 96. STRYKER REVENUES, BY SEGMENT ($MILLION)
  • 97. STRYKER REVENUES, BY GEOGRAPHY ($MILLION)
  • 98. SYNTHES REVENUES AND R&D EXPENSES ($MILLION)
  • 99. SYNTHES REVENUES, BY GEOGRAPHY ($MILLION)
  • 100. WRIGHT MEDICAL REVENUES AND R&D EXPENSES ($MILLION)
  • 101. WRIGHT MEDICAL REVENUES, BY SEGMENTS ($MILLION)
  • 102. WRIGHT MEDICAL REVENUES, BY GEOGRAPHY ($MILLION)

LIST OF FIGURES

  • 1. BRAZIL BIOMATERIALS MARKET
  • 2. EVOLUTION OF BIOMATERIALS
  • 3. PARENTAL STRUCTURE OF BIOMATERIALS MARKET
  • 4. CHARACTERISTICS OF BIOMATERIALS SCIENCE
  • 5. BIOMATERIALS MARKET: SEGMENTATION
  • 6. BRAZIL: MARKET SHARE OF BIOMATERIALS PRODUCTS (2010)
  • 7. BRAZIL: TYPES OF BIOMATERIALS (2010)
  • 8. PRODUCT CLASSIFICATION LEVELS
  • 9. FACTORS AFFECTING THE GROWTH OF BRAZIL BIOMATERIALS MARKET
Back to Top